TrialStroke2021

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.

Andrew M Demchuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.